Where to Buy Semaglutide (Wegovy / Ozempic) in Europe: 2026 Guide
Semaglutide is the most searched weight loss medication in Europe. This guide covers dosing, side effects, how Wegovy differs from Ozempic, and how to source it online in the EU.
What Is Semaglutide and How Does It Work?
Semaglutide is a GLP-1 receptor agonist — it mimics the glucagon-like peptide-1 hormone that is released after eating. It slows gastric emptying, reduces appetite via hypothalamic signalling, and increases insulin secretion in a glucose-dependent manner. The result is consistent, sustained weight loss of 15–17% of body weight over 68 weeks in clinical trials (STEP trials), compared to 2.4% with placebo. For context: no previous weight-loss drug had ever achieved consistent double-digit percentage weight loss.
Wegovy vs Ozempic: What Is the Difference?
Both contain semaglutide. The key differences: Ozempic (0.5–2 mg weekly) is licensed for Type 2 diabetes management; Wegovy (0.25–2.4 mg weekly) is specifically licensed for chronic weight management. The dosing protocol for Wegovy is more gradual — starting at 0.25 mg/week for 4 weeks, escalating every 4 weeks to a maintenance dose of 2.4 mg/week. This slower titration significantly reduces nausea and GI side effects. Ozempic at 2 mg weekly produces comparable weight loss but is technically off-label for non-diabetic obesity.
Expected Weight Loss and Timeline
Weeks 1–4: minimal weight change while body adapts. Weeks 4–16: 2–4 kg loss as appetite suppression strengthens. Months 4–12: most significant weight loss period — 1–2 kg/month. Month 12–18: plateau at 15–17% total body weight loss for most patients. To put this in concrete terms: a 100 kg patient typically reaches 83–85 kg by month 12–16. These results require consistent weekly injections and caloric deficit. Exercise accelerates results and preserves lean mass.
Side Effects: What to Expect
Most common (>10%): nausea, vomiting, diarrhoea, constipation. Nausea typically peaks at dose escalation and resolves within 2–4 weeks. To minimise: eat smaller meals, avoid fatty or spicy foods, take injection on an empty stomach or before bed. Serious but rare: pancreatitis (discontinue if severe abdominal pain), gallbladder disease, increased heart rate. Contraindicated in: personal or family history of medullary thyroid carcinoma, MEN-2 syndrome, known hypersensitivity.
Where to Buy Semaglutide in Europe
PharmaForce stocks GLP-1 weight loss injectables for EU delivery including Ozempic, Wegovy, Mounjaro (tirzepatide) and Saxenda (liraglutide). All products are original pharmaceutical grade from verified EU suppliers. Available for delivery to Germany, France, Poland, Netherlands, Belgium, Austria, Switzerland, Italy, Spain and 25+ European countries. Standard delivery 3–8 business days. No customs fees or import duties for EU residents. Discreet packaging.
Written by
Dr. Anna Fischer
Endocrinologist, MD